B. Riley Has Positive Forecast for Lam Research Q2 Earnings

Lam Research Corporation (NASDAQ:LRCX) – Equities researchers at B. Riley increased their Q2 2026 earnings per share estimates for Lam Research in a research report issued on Wednesday, October 22nd. B. Riley analyst C. Ellis now anticipates that the semiconductor company will post earnings of $1.14 per share for the quarter, up from their prior estimate of $1.06. B. Riley has a “Buy” rating and a $175.00 price objective on the stock. The consensus estimate for Lam Research’s current full-year earnings is $3.71 per share. B. Riley also issued estimates for Lam Research’s Q3 2026 earnings at $1.09 EPS, Q4 2026 earnings at $1.13 EPS, FY2026 earnings at $4.63 EPS, Q1 2027 earnings at $1.18 EPS, Q2 2027 earnings at $1.23 EPS, Q3 2027 earnings at $1.24 EPS, Q4 2027 earnings at $1.32 EPS and FY2027 earnings at $4.97 EPS.

Other equities research analysts also recently issued reports about the company. UBS Group set a $165.00 target price on Lam Research and gave the stock a “buy” rating in a report on Thursday. Citigroup lifted their target price on Lam Research from $120.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday. Stifel Nicolaus set a $160.00 target price on Lam Research and gave the stock a “buy” rating in a report on Thursday. Barclays set a $142.00 price target on Lam Research and gave the stock an “equal weight” rating in a report on Monday. Finally, TD Cowen increased their price target on Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and an average price target of $144.85.

Lam Research Trading Up 4.5%

Shares of LRCX stock opened at $147.54 on Friday. The company has a market cap of $186.05 billion, a P/E ratio of 32.50, a PEG ratio of 1.71 and a beta of 1.84. The stock has a 50 day simple moving average of $122.19 and a two-hundred day simple moving average of $98.97. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. Lam Research has a fifty-two week low of $56.32 and a fifty-two week high of $153.70.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 61.89% and a net margin of 29.66%.The firm’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Natural Investments LLC lifted its holdings in shares of Lam Research by 2.4% in the third quarter. Natural Investments LLC now owns 3,408 shares of the semiconductor company’s stock valued at $456,000 after purchasing an additional 79 shares in the last quarter. Relyea Zuckerberg Hanson LLC lifted its holdings in shares of Lam Research by 2.2% in the third quarter. Relyea Zuckerberg Hanson LLC now owns 3,675 shares of the semiconductor company’s stock valued at $492,000 after purchasing an additional 80 shares in the last quarter. Ignite Planners LLC lifted its holdings in shares of Lam Research by 1.9% in the third quarter. Ignite Planners LLC now owns 5,269 shares of the semiconductor company’s stock valued at $706,000 after purchasing an additional 100 shares in the last quarter. Toth Financial Advisory Corp increased its position in shares of Lam Research by 10.0% during the third quarter. Toth Financial Advisory Corp now owns 1,100 shares of the semiconductor company’s stock valued at $147,000 after acquiring an additional 100 shares during the last quarter. Finally, Moss Adams Wealth Advisors LLC increased its position in shares of Lam Research by 3.2% during the third quarter. Moss Adams Wealth Advisors LLC now owns 3,189 shares of the semiconductor company’s stock valued at $428,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Insider Buying and Selling at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.31% of the stock is owned by corporate insiders.

Lam Research Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were issued a $0.26 dividend. This is a boost from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 24th. Lam Research’s dividend payout ratio is 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.